TLCR Reading Tools
How to cite item
Selecting optimal immunotherapy based on inflammation in stage IV PD-L1 ≥50% gene mutation-negative non-small cell lung cancer: pembrolizumab monotherapy versus combination chemoimmunotherapy
Citation Format
ABNT
APA
BibTeX
CBE
EndNote - EndNote format (Macintosh & Windows)
MLA
ProCite - RIS format (Macintosh & Windows)
RefWorks
Reference Manager - RIS format (Windows only)
Turabian
@article{{TLCR}{108686}, author = {Kunimatsu, Y., Nishioka, N., Yamada, T., Kawachi, H., Tamiya, M., Negi, Y., Goto, Y., Nakao, A., Shiotsu, S., Tanimura, K., Takeda, T., Okada, A., Harada, T., Date, K., Chihara, Y., Hasegawa, I., Tamiya, N., Ishida, M., Kijima, T., Takayama, K.}, title = {Selecting optimal immunotherapy based on inflammation in stage IV PD-L1 ≥50% gene mutation-negative non-small cell lung cancer: pembrolizumab monotherapy versus combination chemoimmunotherapy}, journal = {Translational Lung Cancer Research}, volume = {14}, number = {11}, year = {2025}, url = {https://tlcr.amegroups.org/article/view/108686} }